133
Participants
Start Date
December 5, 2017
Primary Completion Date
July 31, 2020
Study Completion Date
July 31, 2020
Open-Label Placebo (OLP)
We are designating this as a behavioral intervention for two reasons: (1) the placebo pill is physiologically inert and is not classified under FDA regulations; and (2) other studies have demonstrated that the efficacy of the placebo pill is strongly dependent on the participants' anticipation of an effect. We are presenting the pill's efficacy in an open and transparent way to the participants, but using a positive frame. We feel that this qualifies the placebo pill use as a behavioral intervention, in the same general category as exercise or relaxation.
Maryland Methadone Treatment Center, Baltimore
University of Maryland, College Park
OTHER
University of Maryland, Baltimore
OTHER